Myomo App Fuses Robotics and Digital Health for Limb Paralysis

BURLINGTON, Mass. – April 20, 2026 – Myomo, Inc., a company at the forefront of wearable medical robotics, has launched a new mobile application designed to create a connected digital ecosystem around its flagship MyoPro device. The Myomo Mobile App, now available on iOS and Android, aims to transform the experience for both individuals with upper-limb paralysis and the clinicians who guide their rehabilitation, making the use of the robotic orthosis more intuitive, data-driven, and engaging.

The MyoPro is a powered arm brace that uses a patient's own muscle signals, detected by non-invasive sensors, to restore movement and function to weakened or paralyzed arms. With the introduction of the app, the company is bridging the gap between its advanced hardware and the growing world of digital health.

“For clinicians, the Myomo Mobile App is designed to simplify device configuration and improve visibility into patient use, whether care is delivered in clinic or remotely,” said Paul R. Gudonis, Myomo’s Chairman and Chief Executive Officer, in the announcement. “For patients, the app helps make muscle activity more understandable and encourages confidence through real-time feedback and easy access to training resources.”

A Digital Bridge for Physical Rehabilitation

The launch of the Myomo Mobile App represents a significant step in the evolution of assistive medical technology, where physical devices are increasingly enhanced by smart, interactive software. The app serves as a central hub, connecting the patient, the clinician, and the MyoPro device itself in a continuous feedback loop.

For clinicians, the app provides a streamlined mobile interface to customize the MyoPro’s settings. Key parameters such as EMG signal gain, activation thresholds, and range of motion can now be adjusted on the fly, either in person or remotely. This capability not only enhances efficiency during clinical appointments but also opens the door for more agile, responsive remote care. Therapists can gain visibility into how a patient is using the device at home—monitoring usage patterns and device configurations—which allows for more proactive follow-up and data-informed adjustments to therapy protocols.

This move mirrors a broader trend across the medical robotics industry. Companies developing exoskeletons and other assistive technologies, like ReWalk Robotics and Ekso Bionics, are increasingly integrating digital platforms to track performance metrics and manage therapy. Myomo's app, however, is distinguished by its tight integration with an upper-limb orthosis, focusing on restoring function for daily living activities. By creating this digital layer, the company is not just adding a feature but fundamentally enhancing how its core technology is delivered and managed.

Empowering Patients and Reshaping Clinical Care

Beyond the clinical benefits, the Myomo Mobile App is designed with a strong focus on patient empowerment. For individuals recovering from a stroke, brachial plexus injury, or other neurological disorders, the path to regaining function can be long and challenging. The app aims to make this journey more transparent and motivating.

Users can now view their own electromyography (EMG) signals in real time on their smartphone or tablet. This visualization makes the abstract concept of muscle activity tangible, helping patients better understand how their own effort translates into movement with the MyoPro. The app includes new graphics that mirror the device's motion and display its current mode, demystifying its operation. Furthermore, patients can track repetitions and other activity metrics at home, providing a sense of progress and accomplishment outside of formal therapy sessions.

This direct feedback is coupled with quick access to a library of training materials and support resources. This encourages independent self-management and helps users build confidence in operating the device on their own. By placing these tools directly in the hands of the patient, Myomo is fostering a more active role in their own rehabilitation, which is widely seen as a key driver of better long-term outcomes. The app transforms the MyoPro from a device that is simply worn to a tool that is actively engaged with, promoting adherence and sustained use.

The Strategic Play Behind the App

From a business perspective, the launch of the Myomo Mobile App is a calculated strategic move. In the competitive landscape of medical technology, a strong digital offering can be a powerful differentiator. The app enhances the overall value proposition of the MyoPro system, making it a more attractive option for patients, caregivers, and healthcare providers alike. By simplifying the clinical workflow, Myomo can reduce barriers to adoption in busy therapy clinics.

Perhaps more importantly, the app positions Myomo to harness the power of data. The press release highlights that the app is built on a "modern digital infrastructure" intended to support "stronger data capture" and "expanded performance analytics." The anonymized, aggregated data collected from a fleet of connected devices can provide invaluable insights for the company's research and development teams. This data can be used to refine algorithms, improve device performance, and inform the design of future products.

This data-driven approach is critical for demonstrating clinical efficacy and value to third-party payers, a crucial factor for any medical device company's financial success. By systematically collecting performance data, Myomo can build a stronger evidence base to support reimbursement claims, which can in turn accelerate market penetration. The app, therefore, is not merely a companion product but a foundational piece of the company's long-term growth strategy, enabling a cycle of continuous improvement and innovation.

Navigating Integration and Data Privacy

While the potential benefits are clear, the successful rollout of a new digital health tool also comes with practical considerations. For clinics, integrating the Myomo Mobile App into established workflows will require training and adaptation. Therapists will need to become proficient with the app's features to leverage its full potential for remote monitoring and device configuration. A key question for many practices will be how, or if, the data from the app can be integrated with their existing Electronic Medical Record (EMR) systems to avoid creating data silos or requiring duplicate entry.

Myomo has made user manuals available on its website, but ongoing support and intuitive design will be critical for widespread adoption among busy healthcare professionals. The initial investment in staff training must be offset by clear gains in efficiency and improved patient outcomes.

Furthermore, as with any application that handles sensitive health information, data security and privacy are paramount. Myomo will be expected to adhere to stringent regulations such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States. This involves implementing robust technical and administrative safeguards to protect patient data from unauthorized access or breaches. The company's claim of a "modern digital infrastructure" suggests an awareness of these responsibilities, which are non-negotiable for building trust with both users and the medical community. Successfully navigating these technical and regulatory challenges will be essential for the app to realize its full potential in reshaping care for individuals with upper-limb paralysis.